| What if you could offer your patients a more complete picture of their breast cancer risk—without adding complexity to your workflow?
The MyRisk Test with RiskScore® combines genetics, clinical factors, and polygenic risk to uncover hereditary cancer genes alone can’t—delivering a more comprehensive risk assessment to support early detection and personalized care.
The MyRisk Test is built for busy clinics and backed by a full support team.
- Easy ordering via EMR, portal, or paper
- Complimentory access to board-certified genetic counselors
- Most patients pay $0 out of pocket1
- Full support for rollout, training, and patient education
Myriad Oncology™ also offers expert rollout coordination, staff training, and patient-first resources to help you build a strong breast cancer risk assessment program.
 |
